Dr Jacob joined Antares’s board in January 2007 bringing over 29 years of pharmaceutical industry experience including having founded InKine Pharmaceutical Company in 1997 and served as chairman and CEO from its founding until the company was acquired by Salix Pharmaceuticals in 2005.
In 1989 Dr Jacob co-founded Magainin Pharmaceuticals and served as its COO until 1996. From 1980 to 1989 he served in a variety of executive roles including worldwide vice president of SmithKline & French Labs (now Glaxo-SmithKline) and as a member of its corporate management committee.
Dr Gonella said: I am confident the company will continue to execute on its business plan and build shareholder value under Dr Jacob’s leadership. He has been a great addition to the board with his vast pharmaceutical experience as both a leader of successful companies and his history of stewardship as a member of multiple and diverse boards. We look forward to continuing to benefit from his wealth of experience, his skill as an executive leader and the additional perspectives that he brings.